BioNexus Gene Lab (BGLC) Capital Expenditures Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 17.42% |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | -12.98% |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 17.87% |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | - |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | -24.33% |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | -8.57% |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | -38.08% |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | -23.96% |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | 47.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.15% |
| Dec 31, 2025 | -61.43% |
| Sep 30, 2025 | -47.15% |
| Jun 30, 2025 | 38.67% |
| Mar 31, 2025 | -34.49% |
| Dec 31, 2024 | 46.51% |
| Sep 30, 2024 | 686.13% |
| Jun 30, 2024 | 40.14% |
| Mar 31, 2024 | 200.71% |
| Dec 31, 2023 | -86.95% |
| Jun 30, 2023 | 2,647.69% |
| Mar 31, 2023 | -30.74% |
| Dec 31, 2022 | 33.57% |
| Sep 30, 2022 | 132.18% |
| Jun 30, 2022 | -49.64% |
| Mar 31, 2022 | 61.35% |
| Dec 31, 2021 | 27.53% |
| Mar 31, 2021 | 26.97% |